First case of drug‐induced liver injury associated with the use of tocilizumab in a patient with COVID‐19

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COVID‐19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine

(2020) Francesco Fontana et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies

(2020) Ming Zhao   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Off‐label Use of Tocilizumab in Patients with SARS‐CoV‐2 Infection

(2020) Simona Di Giambenedetto et al.   JOURNAL OF MEDICAL VIROLOGY

Letter to the Editor: Acute hypertriglyceridemia in patients with COVID‐19 receiving tocilizumab

(2020) Austin R. Morrison et al.   JOURNAL OF MEDICAL VIROLOGY

COVID‐19 and liver disease

(2020) Jian Sun et al.   LIVER INTERNATIONAL

Effective treatment of severe COVID-19 patients with tocilizumab

(2020) Xiaoling Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

EASL Clinical Practice Guidelines: Drug-induced liver injury

(2019) Raúl Andrade et al.   JOURNAL OF HEPATOLOGY

Tocilizumab (Actemra)

(2017) Martin Sheppard et al.   Human Vaccines & Immunotherapeutics